Children’s National Hospital spinout ReveraGen BioPharma gearing up for muscular dystrophy drug launch


ReveraGen BioPharma just won FDA approval for a treatment it's been developing for 15 years.

Previous Women of Influence: Jessie Beegle, Lifepoint Health
Next Couple picks Highlands Ranch for second beer spa location